Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Lowering HCV Drug List Prices With Authorized Generics

Sep 25 2018

• By Cathy Kelly

Drug costs_1C_546120055_1200.jpg

Related Content

Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives

Jul 16 2018

Lilly Likes Concept Of Low-Cost Brand Alternatives As ‘Glide Path’ To No Rebates

Aug 06 2018

Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates

Aug 07 2018

Gilead’s HCV Authorized Generics Effort Will Draw Market Share From AbbVie

Sep 24 2018

Related Companies

Gilead Sciences, Inc.

Viatris Inc.

Eli Lilly and Company

Express Scripts Holding Company

Additional Topics

United States Pricing Debate Pricing Strategies Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window